share_log

T2 Biosystems | PRE 14A: Preliminary proxy statements relating to merger or acquisition

T2 Biosystems | PRE 14A: Preliminary proxy statements relating to merger or acquisition

T2 Biosystems | PRE 14A：並購重組委托聲明
美股SEC公告 ·  11/08 17:05

Moomoo AI 已提取核心訊息

T2 Biosystems, Inc. (TTOO.US), a leader in the development of innovative medical diagnostic equipment, has announced the scheduling of its 2024 Annual Meeting of Stockholders to be held on December 30, 2024. The meeting will be conducted solely via live webcast, allowing stockholders to participate, vote, and submit questions online. The company has outlined several key proposals for the meeting, including the election of three directors, Laura Adams, Robin Toft, and Seymour Liebman, to serve until the 2027 annual meeting, the approval of the amendment and restatement of the 2014 Incentive Award Plan, and the ratification of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. The company is leveraging SEC rules that permit proxy materials to be furnished over the Internet, reducing environmental impact and printing costs. Stockholders of record as of November 5, 2024, are entitled to vote at the meeting. The company has emphasized the importance of stockholder votes, urging participation in the meeting or prompt voting by proxy.
T2 Biosystems, Inc. (TTOO.US), a leader in the development of innovative medical diagnostic equipment, has announced the scheduling of its 2024 Annual Meeting of Stockholders to be held on December 30, 2024. The meeting will be conducted solely via live webcast, allowing stockholders to participate, vote, and submit questions online. The company has outlined several key proposals for the meeting, including the election of three directors, Laura Adams, Robin Toft, and Seymour Liebman, to serve until the 2027 annual meeting, the approval of the amendment and restatement of the 2014 Incentive Award Plan, and the ratification of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024. The company is leveraging SEC rules that permit proxy materials to be furnished over the Internet, reducing environmental impact and printing costs. Stockholders of record as of November 5, 2024, are entitled to vote at the meeting. The company has emphasized the importance of stockholder votes, urging participation in the meeting or prompt voting by proxy.
T2生物系統公司（TTOO.US）是醫療診斷設備創新領域的領導者，宣佈其2024年股東年會定於2024年12月30日舉行。會議將完全通過網絡直播進行，股東可以在線參與、投票和提問。公司已提出會議的幾項重要提案，包括選舉三名董事Laura Adams、Robin Toft和Seymour Liebman，任期至2027年年會結束，批准修訂2014年激勵獎計劃，並批准BDO美國限責合夥公司爲截至2024年12月31日的財政年度獨立註冊會計師。公司正在利用SEC規定，允許通過互聯網提供代理材料，減少環境影響和印刷成本。截至2024年11月5日記錄日期的股東有權參加會議投票。公司強調了股東投票的重要性，敦促參加會議或及時通過代理投票。
T2生物系統公司（TTOO.US）是醫療診斷設備創新領域的領導者，宣佈其2024年股東年會定於2024年12月30日舉行。會議將完全通過網絡直播進行，股東可以在線參與、投票和提問。公司已提出會議的幾項重要提案，包括選舉三名董事Laura Adams、Robin Toft和Seymour Liebman，任期至2027年年會結束，批准修訂2014年激勵獎計劃，並批准BDO美國限責合夥公司爲截至2024年12月31日的財政年度獨立註冊會計師。公司正在利用SEC規定，允許通過互聯網提供代理材料，減少環境影響和印刷成本。截至2024年11月5日記錄日期的股東有權參加會議投票。公司強調了股東投票的重要性，敦促參加會議或及時通過代理投票。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間